A Cloud-Based Infrastructure for Cancer Genomics

Abstract

<p>The advent of new genomic approaches, particularly next generation sequencing (NGS) has resulted in explosive growth of biological data. As the size of biological data keeps growing at exponential rates, new methods for data management and data processing are becoming essential in bioinformatics and computational biology. Indeed, data analysis has now become the central challenge in genomics. </p><p>NGS has provided rich tools for defining genomic alterations that cause cancer. The processing time and computing requirements have now become a serious bottleneck to the characterization and analysis of these genomic alterations. Moreover, as the adoption of NGS continues to increase, the computing power required often exceeds what any single institution can provide, leading to major restraints in the type and number of analyses that can be performed. </p><p>Cloud computing represents a potential solution to this problem. On a cloud platform, computing resources can be available on-demand, thus allowing users to implement scalable and highly parallel methods. However, few centralized frameworks exist to allow the average researcher the ability to apply bioinformatics workflows using cloud resources. Moreover, bioinformatics approaches are associated with multiple processing challenges, such as the variability in the methods or data used and the reproducibility requirements of the research analysis. </p><p>Here, we present CloudConductor, a software system that is specifically designed to harness the power of cloud computing to perform complex analysis pipelines on large biological datasets. CloudConductor was designed with five central features in mind: scalability, modularity, parallelism, reproducibility and platform agnosticism. </p><p>We demonstrate the processing power afforded by CloudConductor on a real-world genomics problem. Using CloudConductor, we processed and analyzed 101 whole genome tumor-normal paired samples from Burkitt lymphoma subtypes to identify novel genomic alterations. We identified a total of 72 driver genes associated with the disease. Somatic events were identified in both coding and non-coding regions of nearly all driver genes, notably in genes IGLL5, BACH2, SIN3A, and DNMT1. We have developed the analysis framework by implementing a graphical user interface, a back-end database system, a data loader and a workflow management system.</p><p>In this thesis, we develop the concepts and describe an implementation of automated cloud-based infrastructure to analyze genomics data, creating a fast and efficient analysis resource for genomics researchers.</p>